Buscar resultados de ensayos clínicos
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - 103 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study Condición:
Fecha: 2012-04-25 Intervenciones: Other: Observational Observational study of subjects previously enrolled in the RAVE trial |
Completed |
Nombre del estudio: Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis Condición:
Fecha: 2006-02-16 Intervenciones: Drug: Rituximab |
Active, not recruiting |
Nombre del estudio: Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis Condición:
Fecha: 2014-06-19 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Condición: Vasculitis Fecha: 2005-08-09 Intervenciones: Drug: azathioprine azathioprine 2 mg/kg oral once daily, duration according to arm |
Completed |
Nombre del estudio: Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides Condición:
Fecha: 2015-06-10 Intervenciones: Other: blood specimen blood specimen for serum rituximab level and serum anti-rituximab level at M1 and |
Recruiting |
Nombre del estudio: Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) Condición:
Fecha: 2005-02-14 Intervenciones:
|
Recruiting |
Nombre del estudio: Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) Condición:
Intervenciones: |
Completed |
Nombre del estudio: Efficacy Study of Two Treatments in the Remission of Vasculitis Condición:
Fecha: 2008-09-05 Intervenciones:
|
Completed |
Nombre del estudio: Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis Condición:
|